目次

Chapter- 1: Introduction
Study Goals and Objectives
Scope of the Report
Reasons for Doing the Study
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter- 2: Summary and Highlights
Market Outlook
Market Summary

Chapter- 3: Market and Technology Background
Introduction
Risk Factors, Causes and Prevention
Symptoms
Pathophysiology and Clinical Subtypes
Prognosis
Epidemiology
Diagnosis
Treatment

Chapter- 4: Market Dynamics
Market Factors
Market Drivers
Market Restraints
Market Opportunities

Chapter- 5: Market Breakdown by Type
Overview
Surgery
Therapeutics
Radiation Therapy

Chapter- 6: Market Breakdown by Disease Stage
Overview
Localized Disease
Regional Disease
Distant Disease

Chapter- 7: Market Breakdown by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 8: Sustainability: An ESG Perspective
Introduction
ESG Practices in the Market for Melanoma Therapeutics
Case Study
BCC Research Viewpoint

Chapter- 9: Emerging Technologies/ Developments
Introduction

Chapter- 10: Regulatory Landscape and Pipeline Analysis
Regulatory Landscape
Pipeline Analysis

Chapter- 11: Patent Analysis
Patent Review by Year
Patent Review by Country
Patent Review

Chapter- 12: Competitive Landscape
Mergers and Acquisitions
Strategic Initiatives
Competitive Analysis

Chapter- 13: Company Profiles
AMGEN INC.
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO.
ERASCA INC.
F. HOFFMANN-LA ROCHE AG
HUYABIO INTERNATIONAL
IOVANCE BIOTHERAPEUTICS INC.
IO BIOTECH
MERCK & CO. INC.
MODERNA INC.
NOVARTIS AG
PFIZER INC.
REGENERON PHARMACEUTICALS INC.